TFRC and breast cancer: Notably, the E3 aptamer also recognizes other TfR1‐positive cancer cells that frequently metastasize to the liver, such as colorectal, pancreatic, lung, and breast cancer,[25, 26] suggesting the broader applicability for SCORT in targeting metastatic cancers.